KCNJ10 and depressive symptom measurement: Evidence that Kir4.1 inhibition increases astrocyte secretion of BDNF [53] led to the hypothesis that Kir4.1 overexpression may participate in the neurobiology of depression by reducing BDNF secretion [40,41].